Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03100474 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT03100474 · ClinicalTrials.gov record · last posted 2025-05-02

Global Registry: ExAblate Neuro MR Guided Focused Ultrasound (MRgFUS) of Neurological Disorders:

StatusActive, Not Recruiting
PhaseNot specified
SponsorInSightec
Started2016-12
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 2, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
A global post approval study to collect safety and effectiveness data related to ExAblate Neuro for the treatment of certain disorders such as Essential Tremor, Parkinson's Movement Disorders, or Neuropathic Pain within the thalamus and/or pallidum.

Amendment record 9 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 9 times since 2017-04-03; most recent amendment 2025-04-30. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2019-07-11
Status change Recruiting→Active, Not Recruitingv4
Trial Details
NCT Number NCT03100474
Lead Sponsor InSightec
Conditions Essential Tremor, Parkinson's Disease, Movement Disorders, Neuropathic Pain
Enrollment 500 participants
Start Date 2016-12
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-05-02